| http://www.w3.org/ns/prov#value | - Some such patients may benefit from treatment with a long-acting bronchodilator (level of evidence: 3B).For patients with more persistent symptoms and moderate to severe airflow obstruction, a long-acting bronchodilator such as tiotropium or SALM should be used to improve dyspnea, exercise endurance and health status and to reduce exacerbation frequency (level
|
